- Home
- AAPG vs MLCO Comparison
AAPG vs MLCO Comparison
Compare AAPG & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAPG | MLCO |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | China | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.2B |
| IPO Year | 2025 | 2006 |
Fundamental Metrics
Financial Performance| Metric | AAPG | MLCO |
|---|---|---|
| Price | $30.00 | $8.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $48.50 | $10.08 |
| AVG Volume (30 Days) | 5.1K | ★ 1.8M |
| Earning Date | 11-19-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $54,524,554.00 | ★ $5,061,044,000.00 |
| Revenue This Year | N/A | $13.64 |
| Revenue Next Year | $368.64 | $3.57 |
| P/E Ratio | ★ N/A | $34.27 |
| Revenue Growth | N/A | ★ 11.46 |
| 52 Week Low | $16.50 | $4.55 |
| 52 Week High | $48.45 | $10.15 |
Technical Indicators
Market Signals| Indicator | AAPG | MLCO |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 48.44 |
| Support Level | $30.00 | $8.41 |
| Resistance Level | $33.09 | $9.53 |
| Average True Range (ATR) | 0.83 | 0.32 |
| MACD | 0.14 | -0.02 |
| Stochastic Oscillator | 72.07 | 32.30 |
Price Performance
Historical ComparisonAbout AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao, with the rest largely from the Philippines as of 2024.